← Back to Search

Procedure

ultrasound image-guided ablation device for Prostate Cancer

N/A
Waitlist Available
Led By Bradford J Wood, M.D.
Research Sponsored by National Institutes of Health Clinical Center (CC)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks after the ablation.
Awards & highlights

Study Summary

This trial is testing a cooled laser applicator system to treat prostate cancer lesions. It will compare using ultrasound vs. MRI to guide the device to the tumor.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks after the ablation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks after the ablation. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To determine the feasibility of treating biopsy-confirmed and MR-visible, low-grade prostate tumor(s) using ultrasound (US) image-guided focal interstitial thermal ablation
Secondary outcome measures
To analyze circulating tumor markers and functional markers in individuals with prostate cancer after receiving treatment over time
To determine changes in imaging and biopsy characteristics after thermal ablation of prostate cancer.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
ultrasound image-guided focal ablation

Find a Location

Who is running the clinical trial?

National Institutes of Health Clinical Center (CC)Lead Sponsor
383 Previous Clinical Trials
880,988 Total Patients Enrolled
4 Trials studying Prostate Cancer
4,057 Patients Enrolled for Prostate Cancer
Bradford J Wood, M.D.Principal InvestigatorNational Institutes of Health Clinical Center (CC)
7 Previous Clinical Trials
4,053 Total Patients Enrolled
1 Trials studying Prostate Cancer
3,894 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any individuals being enrolled in this research endeavor at the present time?

"As seen on the clinicaltrials.gov website, this medical study is suspended and no longer looking for participants. It was first posted in October of 2017 and updated last November 3rd 2022; however, 1,321 other trials are currently open to enrollment across different areas of research."

Answered by AI
~3 spots leftby Jan 2026